200 related articles for article (PubMed ID: 15226316)
1. Soluble, oligomeric, and ligand-binding extracellular domain of the human alpha7 acetylcholine receptor expressed in yeast: replacement of the hydrophobic cysteine loop by the hydrophilic loop of the ACh-binding protein enhances protein solubility.
Avramopoulou V; Mamalaki A; Tzartos SJ
J Biol Chem; 2004 Sep; 279(37):38287-93. PubMed ID: 15226316
[TBL] [Abstract][Full Text] [Related]
2. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
[TBL] [Abstract][Full Text] [Related]
3. Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding.
Psaridi-Linardaki L; Mamalaki A; Remoundos M; Tzartos SJ
J Biol Chem; 2002 Jul; 277(30):26980-6. PubMed ID: 12015305
[TBL] [Abstract][Full Text] [Related]
4. Expression of water-soluble, ligand-binding concatameric extracellular domains of the human neuronal nicotinic receptor alpha4 and beta2 subunits in the yeast Pichia pastoris: glycosylation is not required for ligand binding.
Stergiou C; Zisimopoulou P; Tzartos SJ
J Biol Chem; 2011 Mar; 286(11):8884-92. PubMed ID: 21252231
[TBL] [Abstract][Full Text] [Related]
5. Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the Cys-loop.
Bitzopoulou K; Kostelidou K; Poulas K; Tzartos SJ
Biochim Biophys Acta; 2008 Sep; 1784(9):1226-33. PubMed ID: 18502212
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble nicotinic acetylcholine receptor formed by alpha7 subunit extracellular domains.
Wells GB; Anand R; Wang F; Lindstrom J
J Biol Chem; 1998 Jan; 273(2):964-73. PubMed ID: 9422757
[TBL] [Abstract][Full Text] [Related]
7. Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit.
Yao Y; Wang J; Viroonchatapan N; Samson A; Chill J; Rothe E; Anglister J; Wang ZZ
J Biol Chem; 2002 Apr; 277(15):12613-21. PubMed ID: 11812776
[TBL] [Abstract][Full Text] [Related]
8. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
Marinou M; Tzartos SJ
Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
[TBL] [Abstract][Full Text] [Related]
9. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
Arias HR
Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
[TBL] [Abstract][Full Text] [Related]
10. Expression of human AChR extracellular domain mutants with improved characteristics.
Lazaridis K; Zisimopoulou P; Giastas P; Bitzopoulou K; Evangelakou P; Sideri A; Tzartos SJ
Int J Biol Macromol; 2014 Feb; 63():210-7. PubMed ID: 24246999
[TBL] [Abstract][Full Text] [Related]
11. Refolding of the Escherichia coli expressed extracellular domain of alpha 7 nicotinic acetylcholine receptor.
Tsetlin VI; Dergousova NI; Azeeva EA; Kryukova EV; Kudelina IA; Shibanova ED; Kasheverov IE; Methfessel C
Eur J Biochem; 2002 Jun; 269(11):2801-9. PubMed ID: 12047391
[TBL] [Abstract][Full Text] [Related]
12. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
Arias HR
Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
[TBL] [Abstract][Full Text] [Related]
13. Future therapeutic strategies in autoimmune myasthenia gravis.
Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
[TBL] [Abstract][Full Text] [Related]
14. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
15. Chemical engineering of a three-fingered toxin with anti-alpha7 neuronal acetylcholine receptor activity.
Mourier G; Servent D; Zinn-Justin S; Ménez A
Protein Eng; 2000 Mar; 13(3):217-25. PubMed ID: 10775664
[TBL] [Abstract][Full Text] [Related]
16. Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line.
Peng JH; Lucero L; Fryer J; Herl J; Leonard SS; Lukas RJ
Brain Res; 1999 Apr; 825(1-2):172-9. PubMed ID: 10216184
[TBL] [Abstract][Full Text] [Related]
17. Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera.
Huang S; Li SX; Bren N; Cheng K; Gomoto R; Chen L; Sine SM
Biochem J; 2013 Sep; 454(2):303-310. PubMed ID: 23800261
[TBL] [Abstract][Full Text] [Related]
18. Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeper.
Papke RL; Stokes C; Williams DK; Wang J; Horenstein NA
Neuropharmacology; 2011 Jan; 60(1):159-71. PubMed ID: 20650284
[TBL] [Abstract][Full Text] [Related]
19. A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.
Lasala M; Corradi J; Bruzzone A; Esandi MDC; Bouzat C
J Biol Chem; 2018 Jul; 293(27):10707-10717. PubMed ID: 29784875
[TBL] [Abstract][Full Text] [Related]
20. A method for soluble overexpression of the alpha7 nicotinic acetylcholine receptor extracellular domain.
Fischer M; Corringer PJ; Schott K; Bacher A; Changeux JP
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3567-70. PubMed ID: 11248118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]